# Akebia Therapeutics

Organization · id `cardio:org-akebia-therapeutics` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Akebia+Therapeutics>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 10 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Akebia Therapeutics
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: 20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia (`cardio:ct-nct01906489`)
- Sponsors: Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (`cardio:ct-nct02648347`)
- Sponsors: Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (`cardio:ct-nct02680574`)
- Sponsors: Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Participants With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD) (`cardio:ct-nct02865850`)
- Sponsors: Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD) (`cardio:ct-nct02892149`)
- Sponsors: A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) (`cardio:ct-nct03254485`)
- Sponsors: Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa (`cardio:ct-nct03799627`)
- Sponsors: Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects (`cardio:ct-nct04707768`)
- Sponsors: Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease (`cardio:ct-nct05085275`)
- Sponsors: To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis (`cardio:ct-nct06901505`)

## Provenance

Content hash: 9d8b176f67cee64ceae194a1d0c49a27826da1d727fb8397651ab13db9486809
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
